Bloomage BioTechnology Corporation Limited (SHA:688363)

SHA:688363 Revenue

Bloomage BioTechnology Corporation had revenue of 829.41M CNY in the quarter ending March 31, 2026, a decrease of -23.06%. This brings the company's revenue in the last twelve months to 3.95B, down -22.36% year-over-year. In the year 2025, Bloomage BioTechnology Corporation had annual revenue of 4.20B, down -21.82%.

• Revenue (ttm): 3.95B
• Revenue Growth: -22.36%
• P/S Ratio: 4.52
• Revenue / Employee: 1.07M
• Employees: 3,698
• Market Cap: 17.85B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.20B	-1.17B	-21.82%
Dec 31, 2024	5.37B	-705.15M	-11.61%
Dec 31, 2023	6.08B	-283.27M	-4.45%
Dec 31, 2022	6.36B	1.41B	28.53%
Dec 31, 2021	4.95B	2.32B	87.93%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error